News Agency
The Times

Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R D, CDMO Commercial Manufacturing Accelerates Revenue Growth

  • Written by PR Newswire
Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R D, CDMO Commercial Manufacturing Accelerates Revenue Growth

Results Highlights for Interim Results ended 30 June 2026Revenue reached RMB1,006.5 million, increasing by 21.0% YoYGross profit amounted to RMB341.7 million, increasing by 0.7% YoYGross profit margin was 34.0%

HONG KONG, Aug. 26, 2026 /PRNewswire/ -- On August 26, 2026, Viva Biotech Holdings Group ("the Group" or "the Company", stock code:...

Read more: Viva Biotech Announces Its 2026 Interim Results: AI Sparks New Paradigm in Drug R D, CDMO...

Selecting Steel Plate for Industrial and Fabrication Projects

Start with the job requirements A successful fabrication project starts with material that suits the work it must perform. Choosing steel plate involves more than selecting a thickness from a stock list. Designers and procurement teams need to consider the load... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion